M V25 (Hydrochlorothiazide and valsartan 25 mg / 320 mg)

Pill imprint M V25 has been identified as Hydrochlorothiazide and valsartan 25 mg / 320 mg.

Hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/valsartan 25 mg / 320 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hydrochlorothiazide and valsartan

Imprint:

M V25

Strength:

25 mg / 320 mg

Color:

Beige

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Angiotensin II inhibitors with thiazides

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-6325

Inactive Ingredients:

silicon dioxide
crospovidone
hypromelloses
lactose monohydrate
FD&C Blue No. 2
magnesium stearate
microcrystalline cellulose
FD&C Yellow No. 6
polydextrose
polyethylene glycol
povidone
corn starch
sodium lauryl sulfate
titanium dioxide
triacetin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.